Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival in a Single-Center Retrospective Cohort [Removal]. (PubMed, Immunotargets Ther) - Sep 2, 2026 - "[This retracts the article DOI: 10.2147/ITT.S603087.]."
Journal • Retrospective data • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • Pediatrics
|